China Universal Asset Management Co., Ltd. Kura Oncology, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,617 shares of KURA stock, worth $312,496. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,617
Previous 15,617
-0.0%
Holding current value
$312,496
Previous $333,000
-0.0%
% of portfolio
0.04%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding KURA
# of Institutions
174Shares Held
80.4MCall Options Held
914KPut Options Held
120K-
Suvretta Capital Management, LLC New York, NY7.07MShares$141 Million6.46% of portfolio
-
Black Rock Inc. New York, NY6.9MShares$138 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$116 Million3.53% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$108 Million2.38% of portfolio
-
Bvf Inc San Francisco, CA4.79MShares$95.8 Million3.06% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.34B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...